The DCCT represents lrgst clinical trial to evaluate whether pts with insulin-depdnt diabetes mellitus whose blood glucose levels are maintained in the normal/near-normal range, will have same, fewer, or more complications than pts whose levels are in usual diabetic range. Retinal changes the major endpoint. Renal, cardiac and neurological assessments also made.
Showing the most recent 10 out of 455 publications